{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:47:07Z","timestamp":1787064427256,"version":"build-2736575974"},"reference-count":36,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Lab Hematology"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The TECHNOSCREEN ADAMTS\u201013 assay (ADSC) is a new lateral flow test which is simple and quick to perform, with a high negative predictive value (NPV); it may improve the diagnostic workflow for TTP. LabPlus in Auckland, New Zealand, performs all ADAMTS13 tests in the Auckland and Northland regions. The ADSC was used at LabPlus between 2022 and 2023 as part of a protocol where results of 0\u2009IU\/mL and 0.1\u2009IU\/mL were confirmed with the TECHNOZYM ADAMTS\u201013 Activity chromogenic ELISA assay (ADATS). The aim was to improve cost efficiency by reducing the need for the labour\u2010intensive ADATS, particularly in low probability requests. This retrospective audit analyses the efficacy and efficiency of the testing protocol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>All ADAMTS\u201013 tests performed in the year before the ADSC (March 2021\u2013March 2022) and after the ADSC protocol was introduced (March 2022\u2013March 2023) were collected from the LabPlus laboratory information system (LIS), and correlated with clinical information from the electronic health record. Statistical analysis was performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Ninety\u2010four test requests were audited. ADSC had an NPV of 100% on diagnostic samples. The protocol increased the median turn\u2010around time (TAT) by 18\u2009h (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.01). If an ADSC of 0.1\u2009IU\/mL was taken as a negative, the median TAT was decreased by 17\u2009h (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0003) in diagnostic samples from LabPlus adjacent hospitals.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ADSC has a high NPV but did not improve TAT when used as part of a testing protocol for our central laboratory receiving samples from a large area.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/ijlh.14413","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T08:16:19Z","timestamp":1734509779000},"page":"304-312","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Real\u2010World Retrospective Audit on the Use of the\n                    <scp>TechnoClone TECHNOSCREEN ADAMTS<\/scp>\n                    \u201013 Assay in the Diagnostic Process for Thrombotic Thrombocytopenic Purpura at\n                    <scp>LabPlus<\/scp>\n                    , New Zealand"],"prefix":"10.1111","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4632-5452","authenticated-orcid":false,"given":"Stephen Hong Chun","family":"Wong","sequence":"first","affiliation":[{"name":"LabPLUS Auckland City Hospital  Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Thalari","sequence":"additional","affiliation":[{"name":"LabPLUS Auckland City Hospital  Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ruskova","sequence":"additional","affiliation":[{"name":"LabPLUS Auckland City Hospital  Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Eaddy","sequence":"additional","affiliation":[{"name":"LabPLUS Auckland City Hospital  Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15006"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102019\u2010130608"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15954"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16188"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2018.10.002"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19026"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185\u2010023\u201003657\u20100"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.14077"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102018\u201002\u2010791533"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V112.11.2291.2291"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12237305"},{"key":"e_1_2_12_13_1","article-title":"Projected Cost Savings of a Plasmic Score\u2010Based Approach to Patients with Suspected Thrombotic Thrombocytopenic Purpura","volume":"130","author":"Upadhyay V. A.","year":"2017","journal-title":"Blood"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12711"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102020\u2010140135"},{"key":"e_1_2_12_16_1","doi-asserted-by":"crossref","unstructured":"M.Griffiths N. B.Binder andH.Vetr \u201cPerformance Evaluation of New Screening Assay for ADAMTS\u201013 Activity \u201d2019Poster Presented at: Gesellscaft Fur Thrombose\u2010 Und Hamostaseforshung 2019 Berlin https:\/\/www.technoclone.com\/sites\/default\/files\/p06\u20107_performance_adamts\u201013_screening_assay_gth2019.pdf.","DOI":"10.1055\/s-0039-1680208"},{"key":"e_1_2_12_17_1","doi-asserted-by":"crossref","unstructured":"M.Griffiths H.Vetr andN. B.Binder \u201cAnalytical performance validation of new screening assay for the deficiency of ADAMTS13 Activity \u201d2019Poster presented at: International Society of Thrombosis and Hemostasis 2019 Melbourne https:\/\/www.technoclone.com\/sites\/default\/files\/pb1585_performance_adamts\u201013_screening_assay_isth2019.pdf.","DOI":"10.1055\/s-0039-1680208"},{"key":"e_1_2_12_18_1","unstructured":"Technoclone Herstellung von Diagnostika und AznerimitteIn GmbH \u201cTechnoscreen ADAMTS13 Act: Semiquantitative Flow Through Assay for the Determination of ADAMTS13 Activity Levels \u201d2024 accessed January 9 2024 https:\/\/www.technoclone.com\/en\/file\/1438\/download?token=ur\u2010I9dj4."},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14815"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102019\u2010128131"},{"key":"e_1_2_12_21_1","unstructured":"Claudia Orange \u201cNorthland region \u201d2024 http:\/\/www.TeAra.govt.nz\/en\/northland\u2010region\/print."},{"key":"e_1_2_12_22_1","unstructured":"M.McClure \u201cAuckland Region \u2010 Facts and Figures \u201d2024 http:\/\/www.TeAra.govt.nz\/en\/auckland\u2010region\/page\u201016."},{"key":"e_1_2_12_23_1","unstructured":"Google Maps \u201cDistance between hospitals in the Auckland and Northland Regions \u201daccessed January 9 2024 maps.google.com."},{"key":"e_1_2_12_24_1","unstructured":"LabPlus Haemostasis Technical Specialist \u201cTechnoscreen(R) ADAMTS\u201013 Activity Screen \u201d2022[Standard Operating Procedure] Published online."},{"key":"e_1_2_12_25_1","unstructured":"LabPlus Haemostasis Technical Specialist \u201cADAMTS\u201013 Activity and Inhibitor Screen Standard Operating Procedure \u201d2023Published online."},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13882"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352\u20103026(17)30026\u20101"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.14175"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S205630"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009150"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2023.100108"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022017860"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2023000501"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12912"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15010"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12461"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12959\u2010023\u201000564\u20106"}],"container-title":["International Journal of Laboratory Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijlh.14413","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T03:33:47Z","timestamp":1741750427000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijlh.14413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1111\/ijlh.14413"],"URL":"https:\/\/doi.org\/10.1111\/ijlh.14413","archive":["Portico"],"relation":{},"ISSN":["1751-5521","1751-553X"],"issn-type":[{"value":"1751-5521","type":"print"},{"value":"1751-553X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"2024-06-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}